However, as we do not have access to participant-reported parameters that allows determining whether it influenced “prostate health” (such as decrease episodes of prostatitis and voiding issues among urology subgroups as well as effects on semen), conclusions based only on PSA levels from this study should be considered carefully. The gene discussed is KLK3; the disease is male reproductive organ cancer.